Toggle navigation
Login
Cart
Contact Us
Search
Search
Player size:
small
large
0
0
Challenges and Opportunities in the Manufacturing of New Treatment Modalities
Jun 1, 2020 9:00am ‐ Jun 1, 2020 10:30am
Credits: None available.
Overview
CE Information
Comments
Speaker(s):
Wilson W. Bryan
, M.D., Director, Office of Tissues and Advanced Therapies, CBER/FDA
Joseph Famulare
, Conference Chair, VP Global Compliance & External Collaboration, Genentech, A Member of the Roche Group
Eric Felz
, Associate Director Validation, Takeda Pharmaceutical Company
Tim Howard
, PE, CPIP, Interim CEO & President, ISPE
Carol Lynch
, President, Head-North America, Sandoz US
×
Credits
Credits: None available.
You must be logged in and own this session in order to post comments.
×
Shopping Cart
Item
Price
Remove